MedTrace Logo

Influence of Esmolol on a Closed-Loop Anesthesia System

NCT00922467 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2016-09-23

No results posted yet for this study

Summary

Main objective is to evaluate the sparing effect of esmolol on the required doses of propofol and remifentanil

Conditions

  • Anesthesia

Interventions

DRUG

NaCl 9/00

Same volume as in the esmolol group

DRUG

Esmolol

1 mg/kg administrated over 10 minutes followed by an infusion of 0,2 mg/kg/hr during all the anesthetic period

Sponsors & Collaborators

  • Hopital Foch

    lead OTHER

Principal Investigators

  • Marc Fischler, MD · Hôpital Foch

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-06-30
Primary Completion
2009-12-31
Completion
2011-12-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00922467 on ClinicalTrials.gov